Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(2):79; doi:10.1093/jnci/djm312
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Method to Visualize Length of Survival in Time-to-Event Studies

Because individuals who have not experienced the event of interest must be censored in time-to-event studies, standard methods of plotting individual survival times are invalid and data are thus usually plotted using Kaplan–Meier survival curves. However, these curves can make differences between groups appear larger than they actually are. To address this problem, Royston et al. (p. 92) developed a log-normal modeling technique to make dot plots and scatter plots of survival data, and they used an imputation method to provide the missing data for . . . [Full Text of this Article]

The Neuropilin NRP2 and Its Role in Anti-Tumor Therapy

Regulation of Telomerase Activity by Human Tumor Viruses

Doxorubicin and Docetaxel for Breast Cancer Therapy

Statins and Cancer Risk Among VA Health System Patients

Gene Knockout Model of Renal Carcinogenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Visualizing Length of Survival in Time-to-Event Studies: A Complement to Kaplan–Meier Plots
Patrick Royston, Mahesh K. B. Parmar, and Douglas G. Altman
J Natl Cancer Inst 2008 100: 92-97. [Abstract] [Full Text] [PDF]

Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
Marcia Bellon and Christophe Nicot
J Natl Cancer Inst 2008 100: 98-108. [Abstract] [Full Text] [PDF]

Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
Michael J. Gray, George Van Buren, Nikolaos A. Dallas, Ling Xia, Xuemei Wang, Anthony D. Yang, Ray J. Somcio, Yvonne G. Lin, Sherry Lim, Fan Fan, Lingegowda S. Mangala, Thiruvengadam Arumugam, Craig D. Logsdon, Gabriel Lopez-Berestein, Anil K. Sood, and Lee M. Ellis
J Natl Cancer Inst 2008 100: 109-120. [Abstract] [Full Text] [PDF]

The Association Between Statins and Cancer Incidence in a Veterans Population
Wildon R. Farwell, Richard E. Scranton, Elizabeth V. Lawler, Robert A. Lew, Mary T. Brophy, Louis D. Fiore, and J. Michael Gaziano
J Natl Cancer Inst 2008 100: 134-139. [Abstract] [Full Text] [PDF]

Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02–98 Randomized Trial
Prudence Francis, John Crown, Angelo Di Leo, Marc Buyse, Ana Balil, Michael Andersson, Bo Nordenskjöld, Istvan Lang, Raimund Jakesz, Daniel Vorobiof, Jorge Gutiérrez, Guy van Hazel, Stella Dolci, Sophie Jamin, Belguendouz Bendahmane, Richard D. Gelber, Aron Goldhirsch, Monica Castiglione-Gertsch, and Martine Piccart-Gebhart On behalf of the BIG 02-98 Collaborative Group
J Natl Cancer Inst 2008 100: 121-133. [Abstract] [Full Text] [PDF]

Kidney-Targeted Birt-Hogg-Dubé Gene Inactivation in a Mouse Model: Erk1/2 and Akt-mTOR Activation, Cell Hyperproliferation, and Polycystic Kidneys
Masaya Baba, Mutsuo Furihata, Seung-Beom Hong, Lino Tessarollo, Diana C. Haines, Eileen Southon, Vishal Patel, Peter Igarashi, W. Gregory Alvord, Robert Leighty, Masahiro Yao, Marcelino Bernardo, Lilia Ileva, Peter Choyke, Michelle B. Warren, Berton Zbar, W. Marston Linehan, and Laura S. Schmidt
J Natl Cancer Inst 2008 100: 140-154. [Abstract] [Full Text] [PDF]

Times to Event: Why Are They Hard to Visualize?
Janet Wittes
J Natl Cancer Inst 2008 100: 80-81. [Extract] [Full Text] [PDF]

Neuropilin-2: A New Molecular Target for Antiangiogenic and Antitumor Strategies
Masashi Narazaki, Marta Segarra, and Giovanna Tosato
J Natl Cancer Inst 2008 100: 81-83. [Extract] [Full Text] [PDF]